Westal Pharmaceuticals Private Limited
About Westal Pharmaceuticals Private Limited
Data last updated:
Westal Pharmaceuticals Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 13 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U33111UP2015PTC069517. Its GSTIN is 09AABCW6311Q1ZU (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Govind Jadon and Pankaj Kumar Rajauriya.
Its last annual general meeting (AGM) was held on 23 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 656 Shivaji Nagar Fathehabad Road, Agra, Uttar Pradesh, India – 283111.
As per the financials filed for FY 2021, the company reported a revenue of ₹30,143, a decline of 80% compared to the previous year. For the same year it recorded a net loss of ₹18,299 (net margin -60.7%) and EBITDA of -₹18,299 (EBITDA margin -60.7%). Revenue has declined at a compounded annual rate (CAGR) of 73% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Westal Pharmaceuticals Private Limited's registered office is in Agra, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address656 Shivaji Nagar Fathehabad Road, Agra, Uttar Pradesh, India – 283111
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Westal Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Westal Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Westal Pharmaceuticals Private Limited, buy the company report.
Financials of Westal Pharmaceuticals Private Limited
FY 2021 filings availableWestal Pharmaceuticals Private Limited reported revenue of ₹30,143 (down 80% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 73% over three years, including a 80% fall in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹18,299 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹18,299 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -60.7% | ||||
| Net Profit Margin | -60.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Westal Pharmaceuticals Private Limited, buy the company report.
Board of directors of Westal Pharmaceuticals Private Limited
Westal Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Govind Jadon | Director | 15 Mar 2018 | 8 Years 7 Months | Current |
| Pankaj Kumar Rajauriya | Director | 13 Mar 2015 | 11 Years 7 Months | Current |
Peer comparison
Westal Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Deepvin Pharmaceuticals Private Limited | ₹31,729 (FY 2024) | -82.0% | Lucknow, Uttar Pradesh, India | |||
| Neopower Pharmaceuticals Private Limited | ₹31,100 (FY 2024) | -93.0% | Hazaribagh, Jharkhand, India | |||
| Kingbuild Pharmaceuticals Private Limited | ₹30,800 (FY 2021) | -52.0% | Surat, Gujarat, India | |||
| Westal Pharmaceuticals Private Limitedthis company | ₹30,143 (FY 2021) | -₹18,299 | -60.7% | -80.0% | Agra, Uttar Pradesh, India | |
| Ssbell Pharmaceuticals Private Limited | ₹30,020 (FY 2025) | -40.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Westal Pharmaceuticals Private Limited, buy the company report.
Auditor
Westal Pharmaceuticals Private Limited is audited by KUMAR ANIL & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMAR ANIL & CO. | FY 2017 | 002016C |
Shareholding
The shareholding of Westal Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Westal Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Westal Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Westal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Westal Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCW6311Q1ZU | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Westal Pharmaceuticals Private Limited, buy the company report.
Recent activity
Westal Pharmaceuticals Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Pravin Kumar Mishra ceased to be Director on 16 Mar 2018.
Frequently asked questions
Westal Pharmaceuticals is an active private limited company based in Agra, Uttar Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 13 March 2015 (11+ years old) and is registered under CIN U33111UP2015PTC069517.
Westal Pharmaceuticals has 2 current directors:
- Govind Jadon - Director
- Pankaj Kumar Rajauriya - Director
The latest financial statements of Westal Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 23 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Westal Pharmaceuticals is 09AABCW6311Q1ZU, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Westal Pharmaceuticals is U33111UP2015PTC069517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Westal Pharmaceuticals was incorporated on 13 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Westal Pharmaceuticals by revenue are Deepvin Pharmaceuticals Private Limited, Neopower Pharmaceuticals Private Limited, Kingbuild Pharmaceuticals Private Limited, Ssbell Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Pravin Kumar Mishra ceased to be Director on 16 Mar 2018. Govind Jadon was appointed as Director on 15 Mar 2018. Pankaj Kumar Rajauriya was appointed as Director on 13 Mar 2015.
The registered office of Westal Pharmaceuticals is at 656 Shivaji Nagar Fathehabad Road, Agra, Uttar Pradesh, India – 283111.
Westal Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Westal Pharmaceuticals is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.